Iceland News Journal
SEE OTHER BRANDS

The most trusted news from Iceland

Press Releases

Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Iceland News Journal.

Tania Zarak Announces Season Finale of 'Cable a Tierra' and Upcoming Season Two

Tania Zarak Announces Season Finale of 'Cable a Tierra' and Upcoming Season Two

Acclaimed podcast to conclude its first season on December 16; new episodes return in February 2025. REYKJAVÍK, ICELAND, December 9, 2024 /⁨EINPresswire.com⁩/ -- International producer and cultural expert Tania Zarak is set to air the season...

NATO Allies must not reward the aggressor but must ensure a just and durable peace in Ukraine

NATO Allies must not reward the aggressor but must ensure a just and durable peace in Ukraine

25 May 2025 DAYTON, OHIO – Negotiations for a just and durable peace in Ukraine must be pursued with unity and resolve and must not reward the aggressor, undermine Ukraine’s sovereignty, or embolden authoritarian regimes, the NATO Parliamentary...

Alvotech Attending Citi's Global Healthcare Conference on December 4, 2024, and Evercore’s HealthCONx Conference on December 5, 2024

Alvotech Attending Citi's Global Healthcare Conference on December 4, 2024, and Evercore’s HealthCONx Conference on December 5, 2024

REYKJAVIK, Iceland, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in Citi’s...

Notice of Results and Investor Presentation

Notice of Results and Investor Presentation

Reykjavík, Nov. 07, 2024 (GLOBE NEWSWIRE) -- (“Amaroq Minerals” or the “Company”) Notice of Results and Investor Presentation TORONTO, ONTARIO – 7 November 2024 – Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ), an independent mine...

Holding(s) in Company

Holding(s) in Company

Reykjavík, Nov. 05, 2024 (GLOBE NEWSWIRE) -- TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Amaroq...

Plan3 Launches the Airline ImPax Report, New Monthly Research Helping Airlines Improve Passenger Disruption Management

Plan3 Launches the Airline ImPax Report, New Monthly Research Helping Airlines Improve Passenger Disruption Management

Leveraging Disruption Data to Transform Airline Recovery Strategies and Enhance Customer Experience REYKJAVIK, ICELAND, December 5, 2024 /⁨EINPresswire.com⁩/ -- Each year, hundreds of millions of passengers are impacted by delays and...

European Medicines Agency Confirms Acceptance of Marketing Authorization Application for AVT05, a Proposed Biosimilar to Simponi® (golimumab)

European Medicines Agency Confirms Acceptance of Marketing Authorization Application for AVT05, a Proposed Biosimilar to Simponi® (golimumab)

REYKJAVIK, Iceland and LONDON, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Advanz Pharma, a UK...

Holding(s) in Company

Holding(s) in Company

Reykjavík, Oct. 31, 2024 (GLOBE NEWSWIRE) -- TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Amaroq...

Alvotech to Report Financial Results for the First Nine Months of 2024 on November 13, 2024, and Host Conference Call on November 14, 2024, at 8:00 am ET

Alvotech to Report Financial Results for the First Nine Months of 2024 on November 13, 2024, and Host Conference Call on November 14, 2024, at 8:00 am ET

REYKJAVIK, Iceland, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, will release financial results for first nine...

Miscellaneous

Miscellaneous

Reykjavik, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Appointment of Nomad and Joint Broker TORONTO, ONTARIO – October 28, 2024 – Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ), an independent mine development company with a substantial land...

Alvotech Meeting Investors and Presenting at the Jefferies 2024 London Healthcare Conference on November 19–20, 2024

Alvotech Meeting Investors and Presenting at the Jefferies 2024 London Healthcare Conference on November 19–20, 2024

REYKJAVIK, Iceland, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the...

Successful Completion of 2024 Exploration Field Season

Successful Completion of 2024 Exploration Field Season

Reykjavík, Oct. 24, 2024 (GLOBE NEWSWIRE) -- (“Amaroq” or the “Corporation” or the “Company”) Successful Completion of 2024 Exploration Field Season **Completion of full 2024 >8,600m exploration programme ahead of schedule** ***First drilling...

Schedule 2(g) Disclosure

Schedule 2(g) Disclosure

Reykjavik, Oct. 22, 2024 (GLOBE NEWSWIRE) -- (“Amaroq” or the “Corporation” or the “Company”) Schedule 2(g) Disclosure TORONTO, ONTARIO – 22 October 2024 - Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ), an independent mine development...

Block Listing Six Monthly Return

Block Listing Six Monthly Return

Reykjavík, Oct. 24, 2024 (GLOBE NEWSWIRE) -- (“Amaroq” or the “Company”) Block Listing Six Monthly Return TORONTO, ONTARIO – October 24, 2024 – Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ First North: AMRQ), an independent mine development company...

Global Lactose Free Food Market Forecast To Reach $29103.34 Billion By 2029 With 11.7% Annual Growth

Global Lactose Free Food Market Forecast To Reach $29103.34 Billion By 2029 With 11.7% Annual Growth

The Business Research Company's Global Lactose Free Food Market Forecast To Reach $29103.34 Billion By 2029 With 11.7% Annual Growth LONDON, GREATER LONDON, UNITED KINGDOM, May 20, 2025 /⁨EINPresswire.com⁩/ -- The Business Research Company’s...

Holding(s) in Company

Holding(s) in Company

NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Amaroq Minerals Ltd. 1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if...

Alvotech Added to Nasdaq Biotech Index Effective Monday December 23, 2024

Alvotech Added to Nasdaq Biotech Index Effective Monday December 23, 2024

Addition is part of the annual reconstitution of the Nasdaq Biotech Index (NBI) Inclusion criteria include minimum market capitalization and daily trading volumes REYKJAVIK, Iceland, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a...

Total Voting Rights and Exercise of Stock Options

Total Voting Rights and Exercise of Stock Options

Reykjavik, Oct. 14, 2024 (GLOBE NEWSWIRE) -- (“Amaroq” or the “Corporation” or the “Company”) Total Voting Rights and Exercise of Stock Options TORONTO, ONTARIO – 14 October 2024 – Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ Iceland: AMRQ), an...

Holding(s) in Company

Holding(s) in Company

Reykjavik, Oct. 14, 2024 (GLOBE NEWSWIRE) -- TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Amaroq...

European Medicines Agency Confirms Acceptance of Marketing Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®

European Medicines Agency Confirms Acceptance of Marketing Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®

REYKJAVIK, Iceland, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the European Medicines...

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions